US Stock MarketDetailed Quotes

UTHR United Therapeutics

Watchlist

272.220
-0.470-0.17%

Close May 16 16:00 ET

272.000
-0.220-0.08%

Post 17:22 ET

12.08BMarket Cap12.89P/E (TTM)

United Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

0.45%376.5M

21.87%978M

17.55%150.7M

33.87%346.2M

-16.30%106.3M

29.82%374.8M

34.15%802.5M

-26.58%128.2M

39.33%258.6M

-14.30%127M

Net income from continuing operations

27.27%306.6M

35.40%984.8M

64.35%217.1M

11.83%267.6M

123.45%259.2M

0.42%240.9M

52.86%727.3M

17.74%132.1M

47.08%239.3M

-32.79%116M

Operating gains losses

----

92.33%-7.1M

-785.71%-6.2M

----

Depreciation and amortization

12.78%15M

3.70%53.2M

3.79%13.7M

3.10%13.3M

1.57%12.9M

6.40%13.3M

2.81%51.3M

4.76%13.2M

4.03%12.9M

2.42%12.7M

Other non cash items

-281.03%-10.5M

-109.33%-4.9M

-163.29%-5M

-118.00%-1.8M

-108.33%-3.9M

147.54%5.8M

-20.33%52.5M

-79.16%7.9M

-67.74%10M

750.91%46.8M

Change In working capital

-68.71%39.8M

30.74%-97.8M

-4.44%-91.7M

730.14%46M

-57.28%-179.3M

87.33%127.2M

18.94%-141.2M

-165.26%-87.8M

84.23%-7.3M

-54.68%-114M

-Change in receivables

-132.95%-28.3M

-169.59%-58.5M

-279.65%-20.3M

124.01%14M

-4,832.14%-138.1M

205.69%85.9M

47.46%-21.7M

-19.86%11.3M

-48.35%-58.3M

91.36%-2.8M

-Change in inventory

-272.00%-9.3M

-1.49%-13.6M

49.64%-7M

-416.67%-3.1M

78.26%-1M

-143.86%-2.5M

-78.67%-13.4M

-13,800.00%-13.9M

92.68%-600K

-253.33%-4.6M

-Change in payables and accrued expense

-32.14%1.9M

28.31%57.1M

-353.85%-23.1M

76.68%39.4M

59.00%38M

125.93%2.8M

456.00%44.5M

126.38%9.1M

12.63%22.3M

-12.13%23.9M

-Change in other working capital

84.15%75.5M

45.02%-82.8M

56.20%-41.3M

-114.68%-4.3M

40.08%-78.2M

-8.69%41M

-33.39%-150.6M

-648.41%-94.3M

257.53%29.3M

-82.52%-130.5M

Cash from discontinued investing activities

Operating cash flow

0.45%376.5M

21.87%978M

17.55%150.7M

33.87%346.2M

-16.30%106.3M

29.82%374.8M

34.15%802.5M

-26.58%128.2M

39.33%258.6M

-14.30%127M

Investing cash flow

Cash flow from continuing investing activities

432.56%735.3M

11.32%-719.6M

122.24%42.1M

-233.40%-313.4M

-34.44%-227.2M

38.45%-221.1M

-66.67%-811.5M

3.32%-189.3M

60.15%-94M

-245.60%-169M

Net PPE purchase and sale

7.51%-38.2M

-65.99%-230.4M

-99.24%-78.7M

4.51%-65.7M

-162.94%-44.7M

-205.93%-41.3M

-14.90%-138.8M

44.05%-39.5M

-195.28%-68.8M

-4.29%-17M

Net business purchase and sale

----

---89.2M

-6,046.67%-89.2M

----

--0

--1.5M

----

Net investment purchase and sale

532.59%777.8M

44.25%-377M

241.28%218.7M

-900.42%-237.1M

-17.63%-178.8M

47.99%-179.8M

-84.70%-676.2M

-23.64%-154.8M

89.25%-23.7M

-512.90%-152M

Net other investing changes

---4.3M

-757.14%-23M

---8.7M

---10.6M

----

--3.5M

----

Cash from discontinued investing activities

Investing cash flow

432.56%735.3M

11.32%-719.6M

122.24%42.1M

-233.40%-313.4M

-34.44%-227.2M

38.45%-221.1M

-66.67%-811.5M

3.32%-189.3M

60.15%-94M

-245.60%-169M

Financing cash flow

Cash flow from continuing financing activities

-2,297.53%-1.07B

-115.78%-11.9M

-267.21%-92.8M

8.57%7.6M

3.35%24.7M

541.82%48.6M

68.30%75.4M

640.00%55.5M

-57.83%7M

125.47%23.9M

Net issuance payments of debt

---100M

--0

Net common stock issuance

---1B

-21.05%-13.8M

---100K

33.33%-200K

---13.5M

--0

-5.56%-11.4M

--0

-50.00%-300K

--0

Proceeds from stock option exercised by employees

-28.86%46.1M

10.92%104.6M

-86.85%7.3M

6.85%7.8M

3.35%24.7M

752.63%64.8M

69.60%94.3M

620.78%55.5M

-56.55%7.3M

121.30%23.9M

Net other financing activities

12.96%-14.1M

64.00%-2.7M

--0

--13.5M

-116.00%-16.2M

---7.5M

--0

Cash from discontinued financing activities

Financing cash flow

-2,297.53%-1.07B

-115.78%-11.9M

-267.21%-92.8M

8.57%7.6M

3.35%24.7M

541.82%48.6M

68.30%75.4M

640.00%55.5M

-57.83%7M

125.47%23.9M

Net cash flow

Beginning cash position

25.65%1.21B

7.42%961.2M

14.57%1.11B

34.22%1.07B

43.06%1.16B

7.42%961.2M

21.13%894.8M

6.42%966.8M

-15.60%795.2M

-2.28%813.3M

Current changes in cash

-78.35%43.8M

271.23%246.5M

1,885.71%100M

-76.46%40.4M

-431.49%-96.2M

348.22%202.3M

-57.46%66.4M

59.12%-5.6M

609.20%171.6M

-116.47%-18.1M

End cash Position

7.56%1.25B

25.65%1.21B

14.57%1.11B

34.22%1.07B

43.06%1.16B

7.42%961.2M

6.42%966.8M

-15.60%795.2M

Free cash flow

1.44%338.3M

12.64%747.6M

-18.83%72M

47.79%280.5M

-44.00%61.6M

21.18%333.5M

39.02%663.7M

-14.71%88.7M

16.94%189.8M

-16.60%110M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	0.45%376.5M	21.87%978M	17.55%150.7M	33.87%346.2M	-16.30%106.3M	29.82%374.8M	34.15%802.5M	-26.58%128.2M	39.33%258.6M	-14.30%127M
Net income from continuing operations	27.27%306.6M	35.40%984.8M	64.35%217.1M	11.83%267.6M	123.45%259.2M	0.42%240.9M	52.86%727.3M	17.74%132.1M	47.08%239.3M	-32.79%116M
Operating gains losses	----	----	----	----	----	----	92.33%-7.1M	-785.71%-6.2M	----	----
Depreciation and amortization	12.78%15M	3.70%53.2M	3.79%13.7M	3.10%13.3M	1.57%12.9M	6.40%13.3M	2.81%51.3M	4.76%13.2M	4.03%12.9M	2.42%12.7M
Other non cash items	-281.03%-10.5M	-109.33%-4.9M	-163.29%-5M	-118.00%-1.8M	-108.33%-3.9M	147.54%5.8M	-20.33%52.5M	-79.16%7.9M	-67.74%10M	750.91%46.8M
Change In working capital	-68.71%39.8M	30.74%-97.8M	-4.44%-91.7M	730.14%46M	-57.28%-179.3M	87.33%127.2M	18.94%-141.2M	-165.26%-87.8M	84.23%-7.3M	-54.68%-114M
-Change in receivables	-132.95%-28.3M	-169.59%-58.5M	-279.65%-20.3M	124.01%14M	-4,832.14%-138.1M	205.69%85.9M	47.46%-21.7M	-19.86%11.3M	-48.35%-58.3M	91.36%-2.8M
-Change in inventory	-272.00%-9.3M	-1.49%-13.6M	49.64%-7M	-416.67%-3.1M	78.26%-1M	-143.86%-2.5M	-78.67%-13.4M	-13,800.00%-13.9M	92.68%-600K	-253.33%-4.6M
-Change in payables and accrued expense	-32.14%1.9M	28.31%57.1M	-353.85%-23.1M	76.68%39.4M	59.00%38M	125.93%2.8M	456.00%44.5M	126.38%9.1M	12.63%22.3M	-12.13%23.9M
-Change in other working capital	84.15%75.5M	45.02%-82.8M	56.20%-41.3M	-114.68%-4.3M	40.08%-78.2M	-8.69%41M	-33.39%-150.6M	-648.41%-94.3M	257.53%29.3M	-82.52%-130.5M
Cash from discontinued investing activities
Operating cash flow	0.45%376.5M	21.87%978M	17.55%150.7M	33.87%346.2M	-16.30%106.3M	29.82%374.8M	34.15%802.5M	-26.58%128.2M	39.33%258.6M	-14.30%127M
Investing cash flow
Cash flow from continuing investing activities	432.56%735.3M	11.32%-719.6M	122.24%42.1M	-233.40%-313.4M	-34.44%-227.2M	38.45%-221.1M	-66.67%-811.5M	3.32%-189.3M	60.15%-94M	-245.60%-169M
Net PPE purchase and sale	7.51%-38.2M	-65.99%-230.4M	-99.24%-78.7M	4.51%-65.7M	-162.94%-44.7M	-205.93%-41.3M	-14.90%-138.8M	44.05%-39.5M	-195.28%-68.8M	-4.29%-17M
Net business purchase and sale	----	---89.2M	-6,046.67%-89.2M	----	----	----	--0	--1.5M	----	----
Net investment purchase and sale	532.59%777.8M	44.25%-377M	241.28%218.7M	-900.42%-237.1M	-17.63%-178.8M	47.99%-179.8M	-84.70%-676.2M	-23.64%-154.8M	89.25%-23.7M	-512.90%-152M
Net other investing changes	---4.3M	-757.14%-23M	---8.7M	---10.6M	----	----	--3.5M	----	----	----
Cash from discontinued investing activities
Investing cash flow	432.56%735.3M	11.32%-719.6M	122.24%42.1M	-233.40%-313.4M	-34.44%-227.2M	38.45%-221.1M	-66.67%-811.5M	3.32%-189.3M	60.15%-94M	-245.60%-169M
Financing cash flow
Cash flow from continuing financing activities	-2,297.53%-1.07B	-115.78%-11.9M	-267.21%-92.8M	8.57%7.6M	3.35%24.7M	541.82%48.6M	68.30%75.4M	640.00%55.5M	-57.83%7M	125.47%23.9M
Net issuance payments of debt	---100M	---100M	---100M	--0	--0	--0	--0	--0	--0	--0
Net common stock issuance	---1B	-21.05%-13.8M	---100K	33.33%-200K	---13.5M	--0	-5.56%-11.4M	--0	-50.00%-300K	--0
Proceeds from stock option exercised by employees	-28.86%46.1M	10.92%104.6M	-86.85%7.3M	6.85%7.8M	3.35%24.7M	752.63%64.8M	69.60%94.3M	620.78%55.5M	-56.55%7.3M	121.30%23.9M
Net other financing activities	12.96%-14.1M	64.00%-2.7M	--0	--0	--13.5M	-116.00%-16.2M	---7.5M	--0	--0	--0
Cash from discontinued financing activities
Financing cash flow	-2,297.53%-1.07B	-115.78%-11.9M	-267.21%-92.8M	8.57%7.6M	3.35%24.7M	541.82%48.6M	68.30%75.4M	640.00%55.5M	-57.83%7M	125.47%23.9M
Net cash flow
Beginning cash position	25.65%1.21B	7.42%961.2M	14.57%1.11B	34.22%1.07B	43.06%1.16B	7.42%961.2M	21.13%894.8M	6.42%966.8M	-15.60%795.2M	-2.28%813.3M
Current changes in cash	-78.35%43.8M	271.23%246.5M	1,885.71%100M	-76.46%40.4M	-431.49%-96.2M	348.22%202.3M	-57.46%66.4M	59.12%-5.6M	609.20%171.6M	-116.47%-18.1M
End cash Position	7.56%1.25B	25.65%1.21B	25.65%1.21B	14.57%1.11B	34.22%1.07B	43.06%1.16B	7.42%961.2M	7.42%961.2M	6.42%966.8M	-15.60%795.2M
Free cash flow	1.44%338.3M	12.64%747.6M	-18.83%72M	47.79%280.5M	-44.00%61.6M	21.18%333.5M	39.02%663.7M	-14.71%88.7M	16.94%189.8M	-16.60%110M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall